Advertisement

Topics

Lartruvo (olaratumab) Approved for Soft-Tissue Cancers

11:10 EDT 19 Oct 2016 | Drugs.com

WEDNESDAY, Oct. 19, 2016 -- Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft-tissue sarcomas, cancers that develop in areas such as the muscles, fat, blood vessels and...

Original Article: Lartruvo (olaratumab) Approved for Soft-Tissue Cancers

NEXT ARTICLE

More From BioPortfolio on "Lartruvo (olaratumab) Approved for Soft-Tissue Cancers"

Quick Search
Advertisement